Oltmans Curtis Gale

Related Filers (3)

Ownership (20)

4
Wednesday, 7/5/2023
AVENUE THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 4/28/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
5
Friday, 1/7/2022
Fulcrum Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
4
Tuesday, 12/21/2021
AVENUE THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/21/2021
AVENUE THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/29/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/7/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 12/7/2020
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/7/2019
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/29/2019
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/23/2019
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/17/2019
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/18/2018
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
3/A
Friday, 8/17/2018
ARRAY BIOPHARMA INC: Initial statement of beneficial ownership of securities
4
Friday, 8/17/2018
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/19/2017
ARRAY BIOPHARMA INC: Statement of changes in beneficial ownership of securities
3
Thursday, 8/17/2017
ARRAY BIOPHARMA INC: Initial statement of beneficial ownership of securities
Show More